{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T23:43:40Z","timestamp":1790811820434,"version":"4.1.0"},"reference-count":97,"publisher":"Oxford University Press (OUP)","license":[{"start":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T00:00:00Z","timestamp":1765843200000},"content-version":"am","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Adherence to statin therapy remains suboptimal and is significantly influenced by demographic and clinical factors. Targeted strategies are needed to improve adherence, particularly in high-risk groups. Adherence to statin therapy is a key determinant of cardiovascular risk reduction, yet real-world adherence remains uncertain across populations. We conducted a systematic review and meta-analysis to estimate the prevalence of good adherence to statin monotherapy and to identify demographic and clinical factors associated with adherence among adults prescribed lipid-lowering therapy for the prevention of atherosclerotic cardiovascular disease. PubMed and Scopus were searched through May 2025 for randomized controlled trials, cohort, nested case control, and cross-sectional studies assessing statin adherence. Data were extracted on study design, participant characteristics, comorbidities, adherence measurement methods and duration, and statin type. Study quality was assessed using the Newcastle-Ottawa Scale, and risk of bias in randomized trials was evaluated with the Cochrane RoB 2 tool. Random-effect meta-analysis, along with subgroup and sensitivity analyses by follow-up duration, adherence thresholds, and study quality, was performed. Seventy-six studies including 5,898,141 participants with a median follow-up of 24 months were analysed. The pooled prevalence of good adherence (\u226580% medication use) was 62.4% (95% CI: 58.3\u201366.5%), with lower adherence in primary prevention compared with secondary prevention settings. Lower adherence was associated with female sex, Black race, smoking, depression, and heart failure, whereas higher adherence was observed among older adults, those with myocardial infarction or hypertension, individuals with multiple comorbidities, and patients receiving polypharmacy. Primary non-adherence was not reported in any included study, and subgroup and sensitivity analyses showed consistent findings. Overall, statin adherence remains suboptimal and is strongly influenced by demographic and clinical factors, underscoring the need for targeted strategies to improve adherence, particularly among high-risk groups.<\/jats:p>","DOI":"10.1093\/eurjpc\/zwaf769","type":"journal-article","created":{"date-parts":[[2025,12,14]],"date-time":"2025-12-14T12:44:48Z","timestamp":1765716288000},"source":"Crossref","is-referenced-by-count":14,"title":["Prevalence and determinants of adherence to statin therapy: a systematic review and meta-analysis"],"prefix":"10.1093","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6088-8935","authenticated-orcid":false,"given":"Athanasios","family":"Basios","sequence":"first","affiliation":[{"name":"Department of Health Sciences, University of Ioannina , St. Niarchou Av, Ioannina 45500 ,","place":["Greece"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8481-579X","authenticated-orcid":false,"given":"Georgios","family":"Markozannes","sequence":"additional","affiliation":[{"name":"Department of Hygiene and Epidemiology, University of Ioannina School of Medicine , Ioannina ,","place":["Greece"]},{"name":"Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London , London ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3712-4181","authenticated-orcid":false,"given":"Evangelia E","family":"Ntzani","sequence":"additional","affiliation":[{"name":"Department of Hygiene and Epidemiology, University of Ioannina School of Medicine , Ioannina ,","place":["Greece"]},{"name":"Department of Health Services, Policy and Practice, School of Public Health, Brown University , RI ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3221-7226","authenticated-orcid":false,"given":"Konstantinos","family":"Christopoulos","sequence":"additional","affiliation":[{"name":"Department of Hygiene and Epidemiology, University of Ioannina School of Medicine , Ioannina ,","place":["Greece"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-5642-1961","authenticated-orcid":false,"given":"Christina A","family":"Chatzi","sequence":"additional","affiliation":[{"name":"Department of Health Sciences, University of Ioannina , St. Niarchou Av, Ioannina 45500 ,","place":["Greece"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7162-3323","authenticated-orcid":false,"given":"Evangelos","family":"Liberopoulos","sequence":"additional","affiliation":[{"name":"First Department of Propaedeutic and Internal Medicine, School of Medicine, National & Kapodistrian University of Athens , Athens ,","place":["Greece"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8452-8472","authenticated-orcid":false,"given":"Konstantinos K","family":"Tsilidis","sequence":"additional","affiliation":[{"name":"Department of Hygiene and Epidemiology, University of Ioannina School of Medicine , Ioannina ,","place":["Greece"]},{"name":"Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London , London ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1296-0693","authenticated-orcid":false,"given":"Maria","family":"Pappa","sequence":"additional","affiliation":[{"name":"Rheumatology and Clinical Immunology Unit, Attikon University Hospital , Athens ,","place":["Greece"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2988-7664","authenticated-orcid":false,"given":"Evangelos C","family":"Rizos","sequence":"additional","affiliation":[{"name":"Department of Health Sciences, University of Ioannina , St. Niarchou Av, Ioannina 45500 ,","place":["Greece"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,12,16]]},"reference":[{"key":"2026010712322369100_zwaf769-B1","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/j.clinthera.2023.09.020","article-title":"Global trends in atherosclerotic cardiovascular disease","volume":"45","author":"Nedkoff","year":"2023","journal-title":"Clin Ther"},{"key":"2026010712322369100_zwaf769-B2","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1161\/HYPERTENSIONAHA.119.14240","article-title":"High blood pressure and cardiovascular disease","volume":"75","author":"Fuchs","year":"2020","journal-title":"Hypertension"},{"key":"2026010712322369100_zwaf769-B3","doi-asserted-by":"crossref","first-page":"6702","DOI":"10.3390\/ijms22136702","article-title":"Renin-angiotensin system in pathogenesis of atherosclerosis and treatment of CVD","volume":"22","author":"Poznyak","year":"2021","journal-title":"Int J Mol Sci"},{"key":"2026010712322369100_zwaf769-B4","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/s41581-020-0278-5","article-title":"Genetics of diabetes mellitus and diabetes complications","volume":"16","author":"Cole","year":"2020","journal-title":"Nat Rev Nephrol"},{"key":"2026010712322369100_zwaf769-B5","doi-asserted-by":"crossref","first-page":"e984","DOI":"10.1161\/CIR.0000000000000973","article-title":"Obesity and cardiovascular disease: a scientific statement from the American Heart Association","volume":"143","author":"Powell-Wiley","year":"2021","journal-title":"Circulation"},{"key":"2026010712322369100_zwaf769-B6","doi-asserted-by":"crossref","first-page":"189","DOI":"10.5551\/jat.RV22015","article-title":"Cigarette smoking and atherosclerotic cardiovascular disease","volume":"31","author":"Ishida","year":"2024","journal-title":"J Atheroscler Thromb"},{"key":"2026010712322369100_zwaf769-B7","doi-asserted-by":"crossref","first-page":"e010931","DOI":"10.1161\/CIRCIMAGING.120.010931","article-title":"Disentangling the links between psychosocial stress and cardiovascular disease","volume":"13","author":"Osborne","year":"2020","journal-title":"Circ Cardiovasc Imaging"},{"key":"2026010712322369100_zwaf769-B8","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/j.jacc.2022.07.004","article-title":"Exercise for primary and secondary prevention of cardiovascular disease: JACC focus seminar 1\/4","volume":"80","author":"Tucker","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"2026010712322369100_zwaf769-B9","first-page":"e563","article-title":"2019 ACC\/AHA guideline on the primary prevention of cardiovascular disease: executive summary: a report of the American College of Cardiology\/American Heart Association task force on clinical practice guidelines","volume":"140","author":"Arnett","year":"2019","journal-title":"Circulation"},{"key":"2026010712322369100_zwaf769-B10","doi-asserted-by":"crossref","first-page":"237","DOI":"10.2147\/VHRM.S379874","article-title":"A heart-healthy diet for cardiovascular disease prevention: where are we now?","volume":"19","author":"Diab","year":"2023","journal-title":"Vasc Health Risk Manag"},{"key":"2026010712322369100_zwaf769-B11","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1177\/2047487319869400","article-title":"Lifestyle factors and high-risk atherosclerosis: pathways and mechanisms beyond traditional risk factors","volume":"27","author":"Lechner","year":"2020","journal-title":"Eur J Prev Cardiol"},{"key":"2026010712322369100_zwaf769-B12","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1161\/CIRCOUTCOMES.115.002418","article-title":"Impact of hospitalization for acute myocardial infarction on adherence to statins among older adults","volume":"9","author":"Kronish","year":"2016","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"2026010712322369100_zwaf769-B13","doi-asserted-by":"crossref","first-page":"5643","DOI":"10.3390\/jcm11195643","article-title":"Effect of statins on all-cause mortality in adults: a systematic review and meta-analysis of propensity score-matched studies","volume":"11","author":"Nowak","year":"2022","journal-title":"J Clin Med"},{"key":"2026010712322369100_zwaf769-B14","doi-asserted-by":"crossref","first-page":"109040","DOI":"10.1016\/j.jdiacomp.2025.109040","article-title":"Adherence to statins and development of atherosclerosis-related events. A systematic review and meta-analysis","volume":"39","author":"Basios","year":"2025","journal-title":"J Diabetes Complications"},{"key":"2026010712322369100_zwaf769-B15","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.jval.2015.06.002","article-title":"Impact of statin adherence on cardiovascular morbidity and all-cause mortality in the primary prevention of cardiovascular disease: a population-based cohort study in Finland","volume":"18","author":"Rannanheimo","year":"2015","journal-title":"Value Health"},{"key":"2026010712322369100_zwaf769-B16","doi-asserted-by":"crossref","first-page":"e020309","DOI":"10.1136\/bmjopen-2017-020309","article-title":"Association between refill adherence to lipid-lowering medications and the risk of cardiovascular disease and mortality in Swedish patients with type 2 diabetes mellitus: a nationwide cohort study","volume":"8","author":"Karlsson","year":"2018","journal-title":"BMJ Open"},{"key":"2026010712322369100_zwaf769-B17","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1186\/s12944-019-1099-z","article-title":"Long-term statin persistence is poor among high-risk patients with dyslipidemia: a real-world administrative claims analysis","volume":"18","author":"Toth","year":"2019","journal-title":"Lipids Health Dis"},{"key":"2026010712322369100_zwaf769-B18","doi-asserted-by":"crossref","first-page":"e000719","DOI":"10.1136\/bmjdrc-2019-000719","article-title":"Adherence to lipid-lowering therapy and risk for cardiovascular disease and death in type 1 diabetes mellitus: a population-based study from the Swedish National Diabetes Register","volume":"8","author":"Hero","year":"2020","journal-title":"BMJ Open Diabetes Res Care"},{"key":"2026010712322369100_zwaf769-B19","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1016\/j.jacc.2017.07.783","article-title":"Adherence tradeoff to multiple preventive therapies and all-cause mortality after acute myocardial infarction","volume":"70","author":"Korhonen","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"2026010712322369100_zwaf769-B20","doi-asserted-by":"crossref","first-page":"e010376","DOI":"10.1161\/JAHA.118.010376","article-title":"Adherence to statin therapy among US adults between 2007 and 2014","volume":"8","author":"Colantonio","year":"2019","journal-title":"J Am Heart Assoc"},{"key":"2026010712322369100_zwaf769-B21","doi-asserted-by":"crossref","first-page":"2940","DOI":"10.1093\/eurheartj\/eht295","article-title":"Adherence to cardiovascular therapy: a meta-analysis of prevalence and clinical consequences","volume":"34","author":"Chowdhury","year":"2013","journal-title":"Eur Heart J"},{"key":"2026010712322369100_zwaf769-B22","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/j.1524-4733.2007.00213.x","article-title":"Medication compliance and persistence: terminology and definitions","volume":"11","author":"Cramer","year":"2008","journal-title":"Value Health"},{"key":"2026010712322369100_zwaf769-B23","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1002\/pds.4334","article-title":"The myths of medication adherence","volume":"26","author":"Gellad","year":"2017","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"2026010712322369100_zwaf769-B24","doi-asserted-by":"crossref","first-page":"217047","DOI":"10.1155\/2015\/217047","article-title":"Medication adherence measures: an overview","volume":"2015","author":"Lam","year":"2015","journal-title":"Biomed Res Int"},{"key":"2026010712322369100_zwaf769-B25","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1093\/eurheartj\/ehy377","article-title":"Standardized classification and framework for reporting, interpreting, and analysing medication non-adherence in cardiovascular clinical trials: a consensus report from the Non-adherence Academic Research Consortium (NARC)","volume":"40","author":"Valgimigli","year":"2019","journal-title":"Eur Heart J"},{"key":"2026010712322369100_zwaf769-B26","first-page":"e105","article-title":"Adherence to statins and LDL-cholesterol goal attainment","volume":"20","author":"Chi","year":"2014","journal-title":"Am J Manag Care"},{"key":"2026010712322369100_zwaf769-B27","doi-asserted-by":"crossref","first-page":"e051121189015","DOI":"10.2174\/1573403X16999201210200342","article-title":"Relationship between hyperlipidemia, cardiovascular disease and stroke: a systematic review","volume":"17","author":"Alloubani","year":"2021","journal-title":"Curr Cardiol Rev"},{"key":"2026010712322369100_zwaf769-B28","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s12872-019-1032-4","article-title":"Long-term statin adherence in patients after hospital discharge for new onset of atherosclerotic cardiovascular disease: a population-based study of real world prescriptions in Taiwan","volume":"19","author":"Chen","year":"2019","journal-title":"BMC Cardiovasc Disord"},{"key":"2026010712322369100_zwaf769-B29","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.cardfail.2011.04.011","article-title":"Impact of medication nonadherence on hospitalizations and mortality in heart failure","volume":"17","author":"Fitzgerald","year":"2011","journal-title":"J Card Fail"},{"key":"2026010712322369100_zwaf769-B30","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jacl.2018.11.004","article-title":"Higher long-term adherence to statins in rural patients at high atherosclerotic risk","volume":"13","author":"Peverelle","year":"2019","journal-title":"J Clin Lipidol"},{"key":"2026010712322369100_zwaf769-B31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta11140","article-title":"A systematic review and economic evaluation of statins for the prevention of coronary events","volume":"11","author":"Ward","year":"2007","journal-title":"Health Technol Assess"},{"key":"2026010712322369100_zwaf769-B32","doi-asserted-by":"crossref","first-page":"e0242424","DOI":"10.1371\/journal.pone.0242424","article-title":"Statin adherence is lower in primary than secondary prevention: a national follow-up study of new users","volume":"15","author":"Sigglekow","year":"2020","journal-title":"PLoS One"},{"key":"2026010712322369100_zwaf769-B33","doi-asserted-by":"crossref","first-page":"e0140008","DOI":"10.1371\/journal.pone.0140008","article-title":"Association of continuity of primary care and statin adherence","volume":"10","author":"Warren","year":"2015","journal-title":"PLoS One"},{"key":"2026010712322369100_zwaf769-B34","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1136\/heartjnl-2013-304960","article-title":"Maintenance of statin use over 3 years following acute coronary syndromes: a national data linkage study (ANZACS-QI-2)","volume":"100","author":"Grey","year":"2014","journal-title":"Heart"},{"key":"2026010712322369100_zwaf769-B35","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1001\/jamacardio.2018.4936","article-title":"Association of statin adherence with mortality in patients with atherosclerotic cardiovascular disease","volume":"4","author":"Rodriguez","year":"2019","journal-title":"JAMA Cardiol"},{"key":"2026010712322369100_zwaf769-B36","doi-asserted-by":"crossref","first-page":"e2025505","DOI":"10.1001\/jamanetworkopen.2020.25505","article-title":"Assessment of trends in statin therapy for secondary prevention of atherosclerotic cardiovascular disease in US adults from 2007 to 2016","volume":"3","author":"Yao","year":"2020","journal-title":"JAMA Netw Open"},{"key":"2026010712322369100_zwaf769-B37","first-page":"892","article-title":"Antihyperlipidemic medication treatment patterns and statin adherence among patients with ASCVD in a managed care plan after release of the 2013 ACC\/AHA guideline on the treatment of blood cholesterol","volume":"22","author":"Bellows","year":"2016","journal-title":"J Manag Care Spec Pharm"},{"key":"2026010712322369100_zwaf769-B38","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1111\/jgs.16037","article-title":"Statin adherence and mortality in patients aged 80 years and older after acute myocardial infarction","volume":"67","author":"Phan","year":"2019","journal-title":"J Am Geriatr Soc"},{"key":"2026010712322369100_zwaf769-B39","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/j.jacl.2016.04.010","article-title":"Predictors of first-year statin medication discontinuation: a cohort study","volume":"10","author":"Halava","year":"2016","journal-title":"J Clin Lipidol"},{"key":"2026010712322369100_zwaf769-B40","first-page":"17","article-title":"Racial differences in adherence to cardiac medications","volume":"95","author":"Charles","year":"2003","journal-title":"J Natl Med Assoc"},{"key":"2026010712322369100_zwaf769-B41","first-page":"e106","article-title":"LDL cholesterol response and statin adherence among high-risk patients initiating treatment","volume":"22","author":"Vupputuri","year":"2016","journal-title":"Am J Manag Care"},{"key":"2026010712322369100_zwaf769-B42","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1016\/j.amjcard.2011.01.013","article-title":"Adherence to statin therapy in elderly patients after hospitalization for coronary revascularization","volume":"107","author":"Kulik","year":"2011","journal-title":"Am J Cardiol"},{"key":"2026010712322369100_zwaf769-B43","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1111\/bcp.14333","article-title":"Real-world evaluation of the impact of statin intensity on adherence and persistence to therapy: a Scottish population-based study","volume":"86","author":"Rezende Macedo do Nascimento","year":"2020","journal-title":"Br J Clin Pharmacol"},{"key":"2026010712322369100_zwaf769-B44","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.atherosclerosis.2016.10.020","article-title":"Drug treatment and adherence of subjects &lt;40 years with diagnosis of heterozygous familial hypercholesterolemia","volume":"254","author":"Casula","year":"2016","journal-title":"Atherosclerosis"},{"key":"2026010712322369100_zwaf769-B45","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1111\/j.1464-5491.2008.02476.x","article-title":"Long-term adherence to statin treatment in diabetes","volume":"25","author":"Donnelly","year":"2008","journal-title":"Diabet Med"},{"key":"2026010712322369100_zwaf769-B46","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1001\/jama.288.4.462","article-title":"Adherence with statin therapy in elderly patients with and without acute coronary syndromes","volume":"288","author":"Jackevicius","year":"2002","journal-title":"JAMA"},{"key":"2026010712322369100_zwaf769-B47","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1177\/2396987316646026","article-title":"Inequalities in medication adherence to statin treatment after stroke: a nationwide observational study","volume":"1","author":"Sj\u00f6lander","year":"2016","journal-title":"Eur Stroke J"},{"key":"2026010712322369100_zwaf769-B48","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1161\/CIRCULATIONAHA.106.665992","article-title":"Adherence to statin therapy under drug cost sharing in patients with and without acute myocardial infarction: a population-based natural experiment","volume":"115","author":"Schneeweiss","year":"2007","journal-title":"Circulation"},{"key":"2026010712322369100_zwaf769-B49","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.amjmed.2003.12.041","article-title":"Adherence to evidence-based therapies after discharge for acute coronary syndromes: an ongoing prospective, observational study","volume":"117","author":"Eagle","year":"2004","journal-title":"Am J Med"},{"key":"2026010712322369100_zwaf769-B50","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1345\/aph.1P150","article-title":"Predictors of nonadherence to statins: a systematic review and meta-analysis","volume":"44","author":"Mann","year":"2010","journal-title":"Ann Pharmacother"},{"key":"2026010712322369100_zwaf769-B51","first-page":"574","article-title":"Proportion and risk indicators of nonadherence to statin therapy: a meta-analysis","volume":"28","author":"Lemstra","year":"2012","journal-title":"Can J Cardiol"},{"key":"2026010712322369100_zwaf769-B52","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1093\/gerona\/glx256","article-title":"A systematic review and meta-analysis of the factors associated with nonadherence and discontinuation of statins among people aged \u226565 years","volume":"73","author":"Ofori-Asenso","year":"2018","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"2026010712322369100_zwaf769-B53","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1111\/j.1742-1241.2011.02706.x","article-title":"Adherence to lipid-lowering agents among 11,042 patients in clinical practice","volume":"65","author":"Wong","year":"2011","journal-title":"Int J Clin Pract"},{"key":"2026010712322369100_zwaf769-B54","first-page":"193","article-title":"Factors of hyperlipidemia medication adherence in a nationwide health plan","volume":"18","author":"Wiegand","year":"2012","journal-title":"Am J Manag Care"},{"key":"2026010712322369100_zwaf769-B55","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1007\/s00228-013-1488-6","article-title":"Adherence to preventive statin therapy according to socioeconomic position","volume":"69","author":"Wallach-Kildemoes","year":"2013","journal-title":"Eur J Clin Pharmacol"},{"key":"2026010712322369100_zwaf769-B56","doi-asserted-by":"crossref","first-page":"e102146","DOI":"10.1371\/journal.pone.0102146","article-title":"Pattern of statin use in southern Italian primary care: can prescription databases be used for monitoring long-term adherence to the treatment?","volume":"9","author":"Ferrajolo","year":"2014","journal-title":"PLoS One"},{"key":"2026010712322369100_zwaf769-B57","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1186\/s13075-014-0443-y","article-title":"Statin initiation and treatment non-adherence following a first acute myocardial infarction in patients with inflammatory rheumatic disease versus the general population","volume":"16","author":"Bohensky","year":"2014","journal-title":"Arthritis Res Ther"},{"key":"2026010712322369100_zwaf769-B58","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s40272-014-0116-y","article-title":"Long-term statin treatment in children with familial hypercholesterolemia: more insight into tolerability and adherence","volume":"17","author":"Braamskamp","year":"2015","journal-title":"Paediatr Drugs"},{"key":"2026010712322369100_zwaf769-B59","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1177\/2047487315597209","article-title":"Determinants of adherence to evidence-based therapy after acute myocardial infarction","volume":"23","author":"Hamood","year":"2016","journal-title":"Eur J Prev Cardiol"},{"key":"2026010712322369100_zwaf769-B60","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1161\/CIRCOUTCOMES.116.002728","article-title":"Socioeconomic inequalities in statin adherence under universal coverage: does sex matter?","volume":"9","author":"Aarnio","year":"2016","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"2026010712322369100_zwaf769-B61","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1007\/s40261-017-0559-3","article-title":"Age-related differences in non-persistence with statin treatment in patients after a transient Ischaemic attack","volume":"37","author":"Wawruch","year":"2017","journal-title":"Clin Drug Investig"},{"key":"2026010712322369100_zwaf769-B62","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1002\/pds.4281","article-title":"Refill adherence and persistence to lipid-lowering medicines in patients with type 2 diabetes: a nation-wide register-based study","volume":"26","author":"Karlsson","year":"2017","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"2026010712322369100_zwaf769-B63","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1159\/000450644","article-title":"Factors affecting adherence to statins in hypercholesterolemic Kuwaiti patients: a cross-sectional study","volume":"26","author":"Al-Foraih","year":"2017","journal-title":"Med Princ Pract"},{"key":"2026010712322369100_zwaf769-B64","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.ejvs.2018.09.023","article-title":"Adherence to prescribed drugs among 65\u201374 year old men diagnosed with abdominal aortic aneurysm or peripheral arterial disease in a screening trial: a VIVA substudy","volume":"57","author":"Qvist","year":"2019","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"2026010712322369100_zwaf769-B65","doi-asserted-by":"crossref","first-page":"e011448","DOI":"10.1161\/JAHA.118.011448","article-title":"Association of diabetes mellitus status and glycemic control with secondary prevention medication adherence after acute myocardial infarction","volume":"8","author":"Adamek","year":"2019","journal-title":"J Am Heart Assoc"},{"key":"2026010712322369100_zwaf769-B66","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1080\/00015385.2020.1794162","article-title":"In-hospital statin initiation characteristics and one-year statin adherence rates in patients hospitalised for acute coronary syndrome","volume":"76","author":"\u015eim\u015fek","year":"2021","journal-title":"Acta Cardiol"},{"key":"2026010712322369100_zwaf769-B67","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.3122\/jabfm.2021.06.210202","article-title":"The relationship between patient medication adherence and following preventive medicine recommendation","volume":"34","author":"Shani","year":"2021","journal-title":"J Am Board Fam Med"},{"key":"2026010712322369100_zwaf769-B68","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.ijcard.2021.03.007","article-title":"Clinical impact and room for improvement of intensity and adherence to lipid lowering therapy: five years of clinical follow-up from 164,565 post-myocardial infarction patients","volume":"332","author":"Schiele","year":"2021","journal-title":"Int J Cardiol"},{"key":"2026010712322369100_zwaf769-B69","first-page":"186","article-title":"Identifying adherent patients to newly initiated statins using previous adherence to chronic medications","volume":"27","author":"Majd","year":"2021","journal-title":"J Manag Care Spec Pharm"},{"key":"2026010712322369100_zwaf769-B70","doi-asserted-by":"crossref","first-page":"5692","DOI":"10.3390\/ijerph19095692","article-title":"Multiple medication adherence and related outcomes in community-dwelling older people on chronic polypharmacy: a retrospective cohort study on administrative claims data","volume":"19","author":"Franchi","year":"2022","journal-title":"Int J Environ Res Public Health"},{"key":"2026010712322369100_zwaf769-B71","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"2026010712322369100_zwaf769-B72","author":"Wells"},{"key":"2026010712322369100_zwaf769-B73","doi-asserted-by":"crossref","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"Rob 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"2026010712322369100_zwaf769-B74","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"2026010712322369100_zwaf769-B75","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"key":"2026010712322369100_zwaf769-B76","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1185\/03007990903126833","article-title":"Good and poor adherence: optimal cut-point for adherence measures using administrative claims data","volume":"25","author":"Karve","year":"2009","journal-title":"Curr Med Res Opin"},{"key":"2026010712322369100_zwaf769-B77","doi-asserted-by":"crossref","first-page":"e025813","DOI":"10.1161\/JAHA.122.025813","article-title":"Intensity of and adherence to lipid-lowering therapy as predictors of major adverse cardiovascular outcomes in patients with coronary heart disease","volume":"11","author":"Mazhar","year":"2022","journal-title":"J Am Heart Assoc"},{"key":"2026010712322369100_zwaf769-B78","first-page":"e596","article-title":"2019 ACC\/AHA guideline on the primary prevention of cardiovascular disease: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"140","author":"Arnett","year":"2019","journal-title":"Circulation"},{"key":"2026010712322369100_zwaf769-B79","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.amjmed.2011.12.013","article-title":"Adherence to drugs that prevent cardiovascular disease: meta-analysis on 376,162 patients","volume":"125","author":"Naderi","year":"2012","journal-title":"Am J Med"},{"key":"2026010712322369100_zwaf769-B80","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1093\/gerona\/glx169","article-title":"Adherence and persistence among statin users aged 65 years and over: a systematic review and meta-analysis","volume":"73","author":"Ofori-Asenso","year":"2018","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"2026010712322369100_zwaf769-B81","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1016\/j.jacc.2016.12.036","article-title":"Statin intolerance and risk of coronary heart events and all-cause mortality following myocardial infarction","volume":"69","author":"Serban","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"2026010712322369100_zwaf769-B82","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.amjmed.2013.01.033","article-title":"Adherence to secondary prevention medications and four-year outcomes in outpatients with atherosclerosis","volume":"126","author":"Kumbhani","year":"2013","journal-title":"Am J Med"},{"key":"2026010712322369100_zwaf769-B83","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.amjmed.2009.01.032","article-title":"Effect of statin adherence on cerebrovascular disease in primary prevention","volume":"122","author":"Perreault","year":"2009","journal-title":"Am J Med"},{"key":"2026010712322369100_zwaf769-B84","doi-asserted-by":"crossref","first-page":"3028","DOI":"10.1161\/CIRCULATIONAHA.108.768986","article-title":"Medication adherence: its importance in cardiovascular outcomes","volume":"119","author":"Ho","year":"2009","journal-title":"Circulation"},{"key":"2026010712322369100_zwaf769-B85","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1002\/clc.23898","article-title":"Adherence with cardiovascular medications and the outcomes in patients with coronary arterial disease: \u201cReal-world\u201d evidence","volume":"45","author":"Chen","year":"2022","journal-title":"Clin Cardiol"},{"key":"2026010712322369100_zwaf769-B86","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s40263-017-0420-5","article-title":"Statin adherence and the risk of stroke: a dose-response meta-analysis","volume":"31","author":"Xu","year":"2017","journal-title":"CNS Drugs"},{"key":"2026010712322369100_zwaf769-B87","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1177\/2047487317695628","article-title":"The impact of medication adherence on clinical outcomes of coronary artery disease: a meta-analysis","volume":"24","author":"Du","year":"2017","journal-title":"Eur J Prev Cardiol"},{"key":"2026010712322369100_zwaf769-B88","doi-asserted-by":"crossref","first-page":"e229953","DOI":"10.1001\/jamanetworkopen.2022.9953","article-title":"Sex-specific risk factors associated with first acute myocardial infarction in young adults","volume":"5","author":"Lu","year":"2022","journal-title":"JAMA Netw Open"},{"key":"2026010712322369100_zwaf769-B89","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1186\/s12877-022-03279-x","article-title":"Prevalence and factors associated with polypharmacy: a systematic review and meta-analysis","volume":"22","author":"Delara","year":"2022","journal-title":"BMC Geriatr"},{"key":"2026010712322369100_zwaf769-B90","doi-asserted-by":"crossref","first-page":"2748","DOI":"10.1016\/j.clinthera.2007.12.022","article-title":"Association between copayment and adherence to statin treatment initiated after coronary heart disease hospitalization: a longitudinal, retrospective, cohort study","volume":"29","author":"Ye","year":"2007","journal-title":"Clin Ther"},{"key":"2026010712322369100_zwaf769-B91","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1001\/jama.288.4.455","article-title":"Long-term persistence in use of statin therapy in elderly patients","volume":"288","author":"Benner","year":"2002","journal-title":"JAMA"},{"key":"2026010712322369100_zwaf769-B92","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.diabres.2017.08.008","article-title":"Clinical significance of diabetes likely induced by statins: evidence from a large population-based cohort","volume":"133","author":"Corrao","year":"2017","journal-title":"Diabetes Res Clin Pract"},{"key":"2026010712322369100_zwaf769-B93","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1111\/ggi.12616","article-title":"Systematic review of the barriers affecting medication adherence in older adults","volume":"16","author":"Yap","year":"2016","journal-title":"Geriatr Gerontol Int"},{"key":"2026010712322369100_zwaf769-B94","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/0277-5379(90)90190-5","article-title":"Correlation of anti-emetic efficacy and plasma levels of ondansetron","volume":"26","author":"Grunberg","year":"1990","journal-title":"Eur J Cancer"},{"key":"2026010712322369100_zwaf769-B95","doi-asserted-by":"crossref","first-page":"e000438","DOI":"10.1136\/openhrt-2016-000438","article-title":"Health system barriers and facilitators to medication adherence for the secondary prevention of cardiovascular disease: a systematic review","volume":"3","author":"Banerjee","year":"2016","journal-title":"Open Heart"},{"key":"2026010712322369100_zwaf769-B96","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.avsg.2024.03.026","article-title":"Barriers to antiplatelet and statin adherence following major vascular intervention","volume":"106","author":"Nguyen","year":"2024","journal-title":"Ann Vasc Surg"},{"key":"2026010712322369100_zwaf769-B97","doi-asserted-by":"crossref","first-page":"29","DOI":"10.2147\/PPA.S502645","article-title":"A systematic review uncovering modifiable influences on statin adherence","volume":"19","author":"Rosenberg","year":"2025","journal-title":"Patient Prefer Adherence"}],"container-title":["European Journal of Preventive Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eurjpc\/advance-article-pdf\/doi\/10.1093\/eurjpc\/zwaf769\/65925418\/zwaf769.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurjpc\/advance-article-pdf\/doi\/10.1093\/eurjpc\/zwaf769\/65925418\/zwaf769.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T17:34:25Z","timestamp":1767807265000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurjpc\/advance-article\/doi\/10.1093\/eurjpc\/zwaf769\/8381680"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,16]]},"references-count":97,"URL":"https:\/\/doi.org\/10.1093\/eurjpc\/zwaf769","relation":{},"ISSN":["2047-4873","2047-4881"],"issn-type":[{"value":"2047-4873","type":"print"},{"value":"2047-4881","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,16]]},"article-number":"zwaf769"}}